Cathie Wood's position in Beam Therapeutics is currently worth $152 Million. That's 1.37% of their equity portfolio (19th largest holding). The investor owns 8.43% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares eleven more times and sold shares on six occasions. The investor's estimated purchase price is $561 Million, resulting in a loss of 73%.